Open Account
العربية
Open Account

Recap: Accelerate Diagnostics Q4 Earnings

Accelerate Diagnostics, Inc. 0.00% Pre

Accelerate Diagnostics, Inc.

AXDX

0.00

Accelerate Diagnostics (NASDAQ:AXDX) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Accelerate Diagnostics missed estimated earnings by -44.0%, reporting an EPS of $-0.89 versus an estimate of $-0.62.

Revenue was up $55 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Accelerate Diagnostics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -1.07 -1.40 -1.4 -1.5
EPS Actual -1.18 -1.31 -1.7 -1.5
Revenue Estimate 3.53M 3.60M 3.35M 2.87M
Revenue Actual 3.30M 2.92M 2.81M 2.97M

To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via